Dr. Paurush Babbar of The Urology Group talks with Lincoln Ware of The Buzz 1230AM about Low-T therapies, breaking down myths and misconceptions.
Dr. Gary Kirsh, president of The Urology Group, was a co-author in this article, recently published in Reviews in Urology.
“Given the number of prostate biopsies performed annually in the United States and associated infectious events as a result, we sought to determine if implementation of a standardized biopsy protocol utilizing antibiotic prophylaxis based on locally derived antibiograms would result in a decrease, relative to a contemporary control population, in the incidence of infection-related complications among community-based practices.”
The Urology Group seeks to help patients with advanced prostate cancer find drugs like Pluvicto that are in short supply. One patient received his medication from Italy due to limited quantities in the U.S. Being your own advocate is essential to making sure you can take advantage of every treatment option available.
A recent article in Romper Magazine revealed that although vasectomies are simpler, safer, and less expensive, tubal ligations (getting one’s “tubes tied”) outpace them 3 to 1 in the United States and are still performed far more often worldwide. In this article The Urology Group’s Dr. Paurush Babbar debunks common myths and fears men have about getting a…